Antibacterial activity of Argemone mexicana L. against multidrug resistant Pseudomonas aeruginosa, isolated from clinical samples

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 2 SUPPL., 2012, Pages

  Sahu, Mahesh C ^a,b   Debata, Nagen K ^b   Padhy, Rabindra N ^a  

^a Buxi Jagabandhu Bidyadhar College   (India)

^b SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

Antibacterial activity; Argemone mexicana; MBC; MIC; Multidrug resistance; Pseudomonas aeruginosa

Indexed keywords

ACETONE; ALCOHOL; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ARGEMONE OIL; CEFOTAXIME; GATIFLOXACIN; GENTAMICIN; IMIPENEM; METHANOL; NETILMICIN; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN; TAZOBACTAM; WATER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGEMONE MEXICANA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISK DIFFUSION; EXTRACTION; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ARGEMONE; ARGEMONE MEXICANA; PSEUDOMONAS AERUGINOSA;

EID: 84865955486     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60316-5     Document Type: Article

References (29)

1. Norrby SR, Nord CE, Finch R Lack of development of new antimicrobial drugs: A potential serious threat to public health. Lancet Infect Dis 2005, 5:115-119.
2. Levy SB, Marshall B Antibacterial resistance worldwide: Causes, challenges and responses. Nature Med 2004, 10:S122-S129.
3. Guardabassi L, Schwarz S, Lloyd DH Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004, 54:321-332.
4. Brown SA Minimum inhibitory concentrations and post-antimicrobial effects as factors in dosage of antimicrobial drugs. J Am Vet Med Assoc 1987, 19:871-872.
5. Alexander M Why microbial predators and parasites do not eliminate their prey and hosts?. Ann Rev Microbiol 1981, 35:113-133.
6. Botzenhart K, Doring G Ecology and epidemiology of Pseudomonas aeruginosa. Pseudomonas aeruginosa as an opportunistic pathogen 1993, 1-18. Plenum, New York. C. Mario, B. Mauro, F. Herman (Eds.).
7. Gould IM, Mackenzie FM Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. Soc Appl Microbiol 2002, 31:78S-84S.
8. Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulous S, Falagas ME Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 2005, 41:149-158.
9. Boothe DM Principles of antimicrobial therapy. Vet Clin Small Anim 2006, 36:1003-1047.
10. Hegreness M, Shoresh N, Damian D, Hartl D, Kishony R Accelerated evolution of resistance in multidrug environments. PNAS USA 2008, 105:13977-13981.
11. Dubey D, Rath S, Sahu MC, Debata NK, Padhy RN Antimicrobials of plant origin against multi-drug resistant bacteria including the TB bacterium and economics of plant-drugs-introspection. Indian J Tradit Know 2012, 11:225-233.
12. Ahmad I, Beg AZ Antimicrobial and photochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J Ethnopharmacol 2001, 74:113-123.
13. Wilcox ML, Graz B, Falquet J Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Trans R Soc Trop Med 2007, 101:1190-1198.
14. Bhattacharjee I, Chatterjee SK, Chatterjee S, Chandra G Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria. Mem Inst Oswaldo Cruz 2006, 101:645-648.
15. Mohana DC, Satish S, Raveesha KA Antibacterial evaluation of some plant extracts against some human pathogenic bacteria. Adv Biol Res 2008, 2:49-55.
16. Singh SK, Pandey VD, Singh A, Singh C Antibacterial activity of seed extracts of Argemone mexicana L. on some pathogenic bacterial strains. Afr J Biotechnol 2009, 8:7077-7081.
17. Mahady GB, Huang Y, Doyle BJ, Locklear T Natural products as antibacterial agents. Studies in natural products chemistry 2008, 423-444. Elsevier BV, Amsterdam. Atta-ur-Rahman (Ed.).
18. Livermore DM Multiple mechanisms of antimicrobials resistance in Pseudomonas aeruginosa. Our worst nightmare?. Clin Infect Dis 2002, 34:634-640.
19. Sahu MC, Dubey D, Rath S, Debata NK, Padhy RN Multidrug Resistance of Pseudomonas aeruginosa as known from surveillance of nosocomial and community infections in an Indian teaching hospital. J Publ Health 2012, 20:413-423.
20. Perez C, Paul M, Bazerque P Antibiotic assay by agar-well diffusion method. Acta Biol Medicin Experim 1990, 15:113-115.
21. Brain KR, Turner TD The practical evaluation of phyto-pharmaceuticals 1975, 57-58. Wright-Scientica, Bristol.
22. Sofowara A Medicinal plants and traditional medicine in Africa 1993, 151-153. Spectrum Books, Ibadan.
23. Harborne JB Phytochemical methods-a guide to modern techniques of plant analysis 1998, 1-302. Chapman and Hall, London.
24. Arenstein AW, Cross SA Local and disseminated disease caused by Pseudomonas aeruginosa. Pseudomonas aeruginosa as an opportunistic pathogen 1993, 223-244. Plenum, New York. C. Mario, B. Mauro, F. Herman (Eds.).
25. Bellido F, Hancock REW Susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents. Pseudomonas aeruginosa as an opportunistic pathogen 1993, 321-348. Plenum, New York. C. Mario, B. Mauro, F. Herman (Eds.).
26. Milatovic D, Brawny A Development of resistance during antibiotic therapy. Eur J Clin Microbiol 1987, 6:234-244.
27. Cabrera EC, Halos SC, Velmonte MA Antibiograms, O serotypes and R plasmids of nosocomial Pseudomonas aeruginosa isolates. Phil J Microbiol Infect Dis 1997, 26:121-128.
28. Ibrahim HA, Ibrahim H Phytochemical screening and toxicity evaluation of the leaves of Argemone mexicana L. (Papaveraceae). Int J P App Sci 2009, 3:39-43.
29. Kreger AS Pathogenesis of Pseudomonas aeruginosa in ocular diseases. Rev Infect Dis 1983, 5:931-935.